[The role of noradrenaline in the development of neurogenic myocardial dystrophy (experimental and clinical findings)].
D000818:Animals; D001011:Aorta / Q000294:innervation; D001949:Bretylium Compounds / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006321:Heart / Q000294:innervation; D006330:Heart Defects, Congenital / Q000601:surgery*; D006331:Heart Diseases / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control; D006801:Humans; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012018:Reflex
D001949:Bretylium Compounds; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine
Rol' noradrenalina v razvitii neĭrogennoĭ distrofii miokarda (éksperimental'nye i klinicheskie dannye.